Cohen Yuval, CEO of Corbus Pharmaceuticals Holdings, Inc. ($CRBP), made three open market sales of company shares over the last 365 days, totaling $579,156. His most recent sale occurred on February 13, 2026. These transactions rank 6,138th among 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions per insider. Yuval Cohen reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 13871 | $7.78 | 174,316.0000 | 17,553,037 | 7.37% | 0.08% |
| Jan. 14, 2026 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | A | Common Stock, par value $0.0001 per share | 50000 | $0.00 | 188,187.0000 | 17,553,037 | 36.18% | 0.28% |
| Jan. 14, 2026 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | A | Stock options (right to buy) | 150000 | $0.00 | 150,000.0000 | 17,553,037 | 9999.99% | 0.85% |
| Oct. 27, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 8973 | $17.14 | 138,187.0000 | 12,232,228 | 6.10% | 0.07% |
| Oct. 27, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock, par value $0.0001 per share | 8973 | $4.26 | 147,160.0000 | 12,232,228 | 6.49% | 0.07% |
| Oct. 24, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock, par value $0.0001 per share | 18660 | $4.26 | 156,847.0000 | 12,232,228 | 13.50% | 0.15% |
| Oct. 24, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 18660 | $17.01 | 138,187.0000 | 12,232,228 | 11.90% | 0.15% |
| Oct. 27, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Stock options (right to buy) | 8973 | $0.00 | 22,106.0000 | 12,232,228 | 28.87% | 0.07% |
| Oct. 24, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Stock options (right to buy) | 18660 | $0.00 | 31,079.0000 | 12,232,228 | 37.52% | 0.15% |
| Feb. 14, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 7134 | $8.76 | 138,187.0000 | 0 | 4.91% | 0.00% |
| Jan. 31, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | A | Common Stock, par value $0.0001 per share | 68100 | $0.00 | 145,321.0000 | 0 | 88.19% | 0.00% |
| Jan. 31, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | A | Stock options (right to buy) | 228800 | $0.00 | 228,800.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 11667 | $42.24 | 84,400.0000 | 0 | 12.14% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock, par value $0.0001 per share | 1770 | $14.10 | 86,170.0000 | 0 | 2.10% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 1770 | $42.24 | 84,400.0000 | 0 | 2.05% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock, par value $0.0001 per share | 2322 | $4.26 | 86,722.0000 | 0 | 2.75% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 2322 | $42.24 | 84,400.0000 | 0 | 2.68% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 7179 | $42.24 | 77,221.0000 | 0 | 8.51% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Options to purchase common stock | 16830 | $0.00 | 32,827.0000 | 0 | 33.89% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Options to purchase common stock | 12487 | $0.00 | 53,831.0000 | 0 | 18.83% | 0.00% |
| June 17, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Options to purchase common stock | 9333 | $0.00 | 11,667.0000 | 0 | 44.44% | 0.00% |
| June 17, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Options to purchase common stock | 1770 | $0.00 | 52,061.0000 | 0 | 3.29% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Options to purchase common stock | 11667 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Options to purchase common stock | 1770 | $0.00 | 31,057.0000 | 0 | 5.39% | 0.00% |
| June 17, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 1770 | $46.02 | 84,400.0000 | 0 | 2.05% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Options to purchase common stock | 2322 | $0.00 | 49,739.0000 | 0 | 4.46% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock, par value $0.0001 per share | 11667 | $30.00 | 96,067.0000 | 0 | 13.82% | 0.00% |
| June 17, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock, par value $0.0001 per share | 9333 | $30.00 | 93,733.0000 | 0 | 11.06% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 12487 | $50.17 | 84,400.0000 | 0 | 12.89% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock, par value $0.0001 per share | 12487 | $4.26 | 96,887.0000 | 0 | 14.80% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 16830 | $50.17 | 84,400.0000 | 0 | 16.63% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock, par value $0.0001 per share | 16830 | $14.10 | 101,230.0000 | 0 | 19.94% | 0.00% |
| June 17, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock, par value $0.0001 per share | 1770 | $4.26 | 86,170.0000 | 0 | 2.10% | 0.00% |
| June 17, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | S | Common Stock, par value $0.0001 per share | 9333 | $46.02 | 84,400.0000 | 0 | 9.96% | 0.00% |
| Feb. 12, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | A | Common Stock, par value $0.0001 per share | 73947 | $0.00 | 84,400.0000 | 0 | 707.42% | 0.00% |
| Feb. 12, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | A | Stock Option (right to buy) | 73947 | $0.00 | 73,947.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Common Stock | 7179 | $4.97 | 7,179.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | M | Options to purchase common stock | 7179 | $4.97 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2023 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Cohen Yuval | Chief Executive Officer | A | Stock Option (right to buy) | 1989546 | $0.00 | 1,949,546.0000 | 0 | 0.00% | 0.00% |